Compare Cita Mineral Investindo Tbk. (CITA) vs Dharma Polimetal Tbk. (DRMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cita Mineral Investindo Tbk. vs Dharma Polimetal Tbk. — how do they compare? Cita Mineral Investindo Tbk. trades at Rp3,200 (market cap 12.67T, 76.7K 24h volume), while Dharma Polimetal Tbk. trades at Rp990 (market cap 4.64T, 567.8K 24h volume). The key difference: Cita Mineral Investindo Tbk. is far larger — about 2.7× Dharma Polimetal Tbk.'s market cap, and Dharma Polimetal Tbk. is more actively traded (567.8K versus 76.7K). Which is the better fit depends on your goals.
| CITA | DRMA | |
|---|---|---|
Market Cap | 12.67T | 4.64T |
Volume | 76.7K | 567.8K |
Lot | 767 | 5.68K |
Turnover | 244.53M | 560.71M |
Average Price | 3,188.19 | 987.5 |
Value | 244.53M | 560.71M |
Indicative Equilibrium Price | 3,200 | 990 |
Indicative Equilibrium Volume | 10 | 25 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cita Mineral Investindo Tbk.
PT Cita Mineral Investindo Tbk based in Tanggerang established formerly under the name PT. Cipta Panelutama on June 27th 1992. Conduct in furniture manufacturing industry both production & marketing. Start the business in furniture panel production which made by particle board & medium density fibreboard to export to Euro and Arabic market. Type of product such as TV, Audio-Video Cable Cabinet, CD Holder, Computer Workstation & Home Entertainment Center.
Read more on CITA →About Dharma Polimetal Tbk.
PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.
Read more on DRMA →
